Hot topics in cellular neuropathology III: using CRISPR/Cas9 technology for deciphering central nervous system disease targets.
作者信息
Hermann Dirk M
机构信息
Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
出版信息
Front Cell Neurosci. 2023 Sep 1;17:1276077. doi: 10.3389/fncel.2023.1276077. eCollection 2023.
Abstract
摘要
相似文献
1
Hot topics in cellular neuropathology III: using CRISPR/Cas9 technology for deciphering central nervous system disease targets.细胞神经病理学热点话题III：利用CRISPR/Cas9技术解析中枢神经系统疾病靶点
Front Cell Neurosci. 2023 Sep 1;17:1276077. doi: 10.3389/fncel.2023.1276077. eCollection 2023.
2
CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models.CRISPR/Cas9 技术作为一种现代遗传操作工具，用于在大动物模型中重现神经退行性疾病。
Curr Gene Ther. 2021;21(2):130-148. doi: 10.2174/1566523220666201214115024.
3
Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.联合病毒转导和 CRISPR/Cas9 基因编辑治疗神经退行性疾病的治疗潜力。
Neurol Sci. 2018 Nov;39(11):1827-1835. doi: 10.1007/s10072-018-3521-0. Epub 2018 Aug 3.
4
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟，有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
5
CRISPR/Cas9 genome editing for neurodegenerative diseases.用于神经退行性疾病的CRISPR/Cas9基因组编辑
EXCLI J. 2023 Jul 3;22:567-582. doi: 10.17179/excli2023-6155. eCollection 2023.
6
CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases.CRISPR/Cas9 新型治疗方法治疗神经退行性疾病。
Life Sci. 2020 Oct 15;259:118165. doi: 10.1016/j.lfs.2020.118165. Epub 2020 Jul 29.
7
CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.CRISPR-Cas9 技术用于创建能够模拟和治疗疾病的生物替身：从发现到最新进展。
Cells. 2022 Nov 15;11(22):3615. doi: 10.3390/cells11223615.
8
Advanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the Brain.CRISPR/Cas9和反义DNA抑制在脑内基因操纵中的体内高级应用
Front Genet. 2016 Jan 12;6:362. doi: 10.3389/fgene.2015.00362. eCollection 2015.
9
CRISPR/Cas9 gene editing technology: a precise and efficient tool for crop quality improvement.CRISPR/Cas9 基因编辑技术：一种用于改善作物品质的精确高效工具。
Planta. 2023 Jul 3;258(2):36. doi: 10.1007/s00425-023-04187-z.
10
Editing the Central Nervous System Through CRISPR/Cas9 Systems.通过CRISPR/Cas9系统编辑中枢神经系统
Front Mol Neurosci. 2019 May 27;12:110. doi: 10.3389/fnmol.2019.00110. eCollection 2019.
引用本文的文献
1
CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer's disease: progress and prospects.基于CRISPR/Cas9的疗法作为治疗阿尔茨海默病的一种有前景的策略：进展与展望
Front Cell Neurosci. 2025 Apr 7;19:1578138. doi: 10.3389/fncel.2025.1578138. eCollection 2025.
本文引用的文献
1
The role of UBE3A in the autism and epilepsy-related Dup15q syndrome using patient-derived, CRISPR-corrected neurons.使用患者来源的、经 CRISPR 校正的神经元研究 UBE3A 在自闭症和癫痫相关的 Dup15q 综合征中的作用。
Stem Cell Reports. 2023 Apr 11;18(4):884-898. doi: 10.1016/j.stemcr.2023.02.002. Epub 2023 Mar 9.
2
An RNA-targeting CRISPR-Cas13d system alleviates disease-related phenotypes in Huntington's disease models.一种靶向 RNA 的 CRISPR-Cas13d 系统可减轻亨廷顿病模型中的疾病相关表型。
Nat Neurosci. 2023 Jan;26(1):27-38. doi: 10.1038/s41593-022-01207-1. Epub 2022 Dec 12.
3
Hot Topics in Cellular Neuropathology II: Promoting Neuronal Plasticity in the Injured Central Nervous System.细胞神经病理学热点话题II：促进受损中枢神经系统中的神经元可塑性
Front Cell Neurosci. 2022 Jun 3;16:927980. doi: 10.3389/fncel.2022.927980. eCollection 2022.
4
Editorial: Hot Topics in Cellular Neuropathology.社论：细胞神经病理学的热点话题
Front Cell Neurosci. 2022 Apr 19;16:895861. doi: 10.3389/fncel.2022.895861. eCollection 2022.
5
CRISPR gRNA phenotypic screening in zebrafish reveals pro-regenerative genes in spinal cord injury.CRISPR gRNA 表型筛选在斑马鱼中揭示了脊髓损伤中的促再生基因。
PLoS Genet. 2021 Apr 29;17(4):e1009515. doi: 10.1371/journal.pgen.1009515. eCollection 2021 Apr.
6
Hot Topics in Cellular Neuropathology.细胞神经病理学热点话题
Front Cell Neurosci. 2020 Dec 2;14:627494. doi: 10.3389/fncel.2020.627494. eCollection 2020.
7
Applying gene-editing technology to elucidate the functional consequence of genetic and epigenetic variation in Alzheimer's disease.应用基因编辑技术阐明阿尔茨海默病中遗传和表观遗传变异的功能后果。
Brain Pathol. 2020 Sep;30(5):992-1004. doi: 10.1111/bpa.12881.
8
A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I.一种高效的 PS 基因编辑系统纠正黏多糖贮积症 I 型的代谢和神经并发症。
Mol Ther. 2020 Jun 3;28(6):1442-1454. doi: 10.1016/j.ymthe.2020.03.018. Epub 2020 Apr 8.
9
In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy.体内 CRISPRa 减少癫痫啮齿动物模型中的癫痫发作并挽救认知缺陷。
Brain. 2020 Mar 1;143(3):891-905. doi: 10.1093/brain/awaa045.
10
Behavioral characterization of a CRISPR-generated TRPA1 knockout rat in models of pain, itch, and asthma.CRISPR 诱导的 TRPA1 基因敲除大鼠在疼痛、瘙痒和哮喘模型中的行为特征。
Sci Rep. 2020 Jan 22;10(1):979. doi: 10.1038/s41598-020-57936-5.
Zotero 插件